Report

  1. Home
  2. MarketsandMarkets

Clinical Microbiology Market Size, Share & Trends by Application (Pharma, Food, Clinical,Manufacturing, Environment), Disease (Respiratory Disease, Blood Stream, GIT, UTI), Product (Instrument, Analyzer, Reagent), End User, and Region - Global Forecast to 2029

Market Report I 2024-05-29 I 339 Pages I MarketsandMarkets

The Clinical microbiology market is projected to reach USD 6.9 billion by 2029 from USD 5.0 billion in 2024 with a CAGR of 6.5% during the forecast period. The clinical microbiology market is experiencing significant growth driven by recent technological advancements in disease diagnostics, such as rapid molecular testing and laboratory automation, aiding faster and more precise detection of infectious agents. Additionally, the rising global incidence of infectious diseases due to population growth, urbanization, and international travel is driving demand for advanced microbiology testing solutions. However, challenges including limited reimbursement policies for microbiology testing procedures and operational barriers like the need for skilled personnel and complex regulatory frameworks pose obstacles to market expansion, particularly in resource-constrained settings. Addressing these challenges will be crucial to improving accessibility and affordability of microbiology testing services worldwide.

"The Instruments segment accounted for a substantial share of the clinical microbiology market, by type in 2023."
The instruments segment is projected to dominate the clinical microbiology industry throughout the forecast period. This segment's substantial market share can be attributed to several factors. Firstly, there is significant adoption of conventional laboratory instruments by researchers and academia, with a notable increase in industry-academia collaborations focused on genomic research. Secondly, advancements in molecular techniques and proteomics, including innovations such as integrating microfluidics with PCR and applying nanotechnology to qPCR techniques, are driving the segment's growth. Lastly, the ongoing trend of laboratory automation among clinical laboratories is contributing to the expansion and prominence of the instruments segment within the clinical microbiology industry.

" By Application Pharmaceutical Application segment accounted for the largest share in the healthcare clinical microbiology market."
The pharmaceuticals segment represents the largest application area within the clinical microbiology industry and is expected to maintain its dominance throughout the forecast period. This significant share can be primarily attributed to the presence of well-established and widely accepted regulations governing microbial contamination evaluation during pharmaceutical manufacturing and raw material procurement. Regulatory bodies such as the WHO, FDA, MHRA (UK), European Medicines Agency (EU), TGA (Australia), and ANVISA (Brazil) have defined stringent guidelines for assessing microbial contamination in excipients and active pharmaceutical ingredients (APIs) to ensure sterile drug manufacturing and microbial load testing of finished pharmaceutical products. Moreover, pharmaceutical manufacturing processes are rigorously monitored and controlled according to various pharmacopeias on a global scale. The increasing production volume of pharmaceutical drugs worldwide also contributes significantly to the growth of this application segment.

"North America to witness the substantial growth rate during the forecast period."
North America, which includes the United States and Canada, holds a leading position in the clinical microbiology market. This region is characterized by its maturity, marked by widespread use of clinical microbiology technologies among key end-users such as hospitals, research laboratories, diagnostic centers, and commercial service providers. Additionally, North America benefits from well-established distribution channels for manufacturers and suppliers of clinical microbiology products. The region's growth is propelled by factors including easy accessibility to and high adoption of advanced diagnostic technologies, supported by substantial per capita healthcare expenditure by the US and Canadian governments annually, along with favorable government regulations that foster industry development.

The break-down of primary participants is as mentioned below:
- By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
- By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
- By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, ROW-10%

Key Players in the Clinical Microbiology Market
The prominent players in the global healthcare clinical microbiology market include BioMerieux (France), Danaher Corporation (US), Becton, Dickinson, and Company (BD) (US), Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Bruker (US), Hologic, Inc. (US), Merck KGaA(Germany), Bio-Rad Laboratories, Inc.(US), QIAGEN(Netherlands), Shimadzu Corporation(Japan), Neogen Corporation (US), Siemens Healthineers AG (Germany). With Emerging players including, Hardy Diagnostics (US), EMSL Analytical, Inc. (US), Lofilchem S.R.L (Italy), TCS Biosciences (UK), Cole-Parmer Instrument Company, LLC (US), Memmert GmbH + Co.KG (Germany), Vacutest Kima S.r.l (Germany), Rapid Micro Biosystems, Inc. (US), Biotechnology Solutions TX, LLC (US), and Arrow Diagnostics Srl (Italy).
Research Coverage:
The report analyzes the Clinical microbiology market and aims to estimate the market size and future growth potential of various market segments, based on type, application, disease, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
- Analysis of Market Dynamics (Rising incidence of infectious diseases, technological advancements in disease diagnostics,), restraints (limited reimbursement policies for clinical microbiology testing products), opportunities (Improving healthcare infrastructure among emerging economies), and challenges (operational barriers related to use of diagnostics tests)
- Products/Innovations: Detailed insights on upcoming technologies, research & development activities, and new service launches in the Clinical microbiology market.
- Market Development: Comprehensive information on the lucrative emerging markets, component, demographics , end-user, and region.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the clinical microbiology market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the clinical microbiology market like BioMerieux (France), Danaher Corporation (US), Becton, Dickinson, and Company (BD) (US), Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Bruker (US), Hologic, Inc. (US) among others.

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.2.1 INCLUSIONS & EXCLUSIONS 41
TABLE 1 CLINICAL MICROBIOLOGY MARKET: INCLUSIONS & EXCLUSIONS 41
1.3 STUDY SCOPE 42
1.3.1 SEGMENTS COVERED 42
FIGURE 1 CLINICAL MICROBIOLOGY MARKET: SEGMENTS COVERED 42
1.3.2 REGIONS COVERED 43
FIGURE 2 CLINICAL MICROBIOLOGY MARKET: REGIONS COVERED 43
1.3.3 YEARS CONSIDERED 43
FIGURE 3 CLINICAL MICROBIOLOGY MARKET: YEARS CONSIDERED 43
1.3.4 CURRENCY CONSIDERED 44
1.3.5 UNITS CONSIDERED 44
1.4 STAKEHOLDERS 44
1.5 SUMMARY OF CHANGES 44
1.5.1 RECESSION IMPACT 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH DATA 46
FIGURE 4 CLINICAL MICROBIOLOGY MARKET: RESEARCH DESIGN 46
2.1.1 SECONDARY DATA 47
2.1.1.1 List of key secondary sources 47
2.1.1.2 Key data from secondary sources 48
2.1.1.3 Objectives of secondary research 48
2.1.2 PRIMARY DATA 49
FIGURE 5 KEY PRIMARY SOURCES FROM DEMAND AND SUPPLY SIDES 49
2.1.2.1 Objectives of primary research 49
2.1.2.2 Key data from primary sources 50
TABLE 2 KEY DATA OBTAINED FROM PRIMARY SOURCES 50
2.1.2.3 Key industry insights 51
2.1.2.4 Breakdown of primaries 51
FIGURE 6 BREAKDOWN OF PRIMARIES: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 51
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 52
2.2 MARKET SIZE ESTIMATION 52
2.2.1 BOTTOM-UP APPROACH 53
2.2.1.1 Company revenue estimation approach 53
FIGURE 8 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 53
2.2.1.2 Company presentations and primary interviews 53
2.2.1.3 Growth forecast 54
2.2.1.4 CAGR projections 54
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 54
2.2.2 TOP-DOWN APPROACH 54
FIGURE 10 CLINICAL MICROBIOLOGY MARKET: TOP-DOWN APPROACH 55
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 56
FIGURE 11 DATA TRIANGULATION 56
2.4 MARKET SHARE ANALYSIS 57
2.5 STUDY ASSUMPTIONS 57
2.6 GROWTH RATE ASSUMPTIONS 57
2.7 RESEARCH LIMITATIONS 58
2.7.1 METHODOLOGY-RELATED LIMITATIONS 58
2.7.2 SCOPE-RELATED LIMITATIONS 58
2.8 RISK ASSESSMENT 58
TABLE 3 CLINICAL MICROBIOLOGY MARKET: RISK ASSESSMENT 58
2.9 IMPACT OF ECONOMIC RECESSION ON CLINICAL MICROBIOLOGY MARKET 59
3 EXECUTIVE SUMMARY 61
FIGURE 12 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 61
FIGURE 13 LABORATORY INSTRUMENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 62
FIGURE 14 MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 63
FIGURE 15 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 63
FIGURE 16 REGIONAL SNAPSHOT OF CLINICAL MICROBIOLOGY MARKET 64
4 PREMIUM INSIGHTS 66
4.1 CLINICAL MICROBIOLOGY MARKET OVERVIEW 66
FIGURE 17 HIGH PREVALENCE OF INFECTIOUS DISEASES AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET 66
4.2 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT AND COUNTRY (2023) 67
FIGURE 18 GERMANY AND INSTRUMENTS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 67
4.3 CLINICAL MICROBIOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD 68
4.4 CLINICAL MICROBIOLOGY MARKET: REGIONAL MIX (2022-2029) 69
FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 69
4.5 CLINICAL MICROBIOLOGY MARKET: DEVELOPED VS. EMERGING MARKETS (2024 VS. 2029) 69
FIGURE 21 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 69
5 MARKET OVERVIEW 70
5.1 INTRODUCTION 70
5.2 MARKET DYNAMICS 70
FIGURE 22 CLINICAL MICROBIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 70
5.2.1 DRIVERS 71
5.2.1.1 Technological advancements in clinical diagnosis and novel molecular diagnostic-based instruments 71
5.2.1.2 Rising incidence of infectious diseases and epidemics 71
5.2.1.3 Increasing R&D programs and public-private investments 72
5.2.2 RESTRAINTS 73
5.2.2.1 Limited reimbursement policies for clinical microbiology testing procedures 73
5.2.3 OPPORTUNITIES 73
5.2.3.1 Improved healthcare infrastructure in emerging countries 73
5.2.4 CHALLENGES 74
5.2.4.1 Operational barriers to diagnostic microbiology tests in emerging countries 74
5.3 PRICING ANALYSIS 75
TABLE 4 AVERAGE SELLING PRICE FOR CLINICAL MICROBIOLOGY TESTING PRODUCTS, 2021-2023 75
FIGURE 23 AVERAGE SELLING PRICE OF CLINICAL MICROBIOLOGY INSTRUMENTS, BY REGION (USD THOUSAND) 77
TABLE 5 AVERAGE SELLING PRICE OF CLINICAL MICROBIOLOGY INSTRUMENTS, BY REGION, 2021-2023 77
5.4 PATENT ANALYSIS 79
FIGURE 24 PATENT ANALYSIS FOR PCR SYSTEMS (JANUARY 2014-APRIL 2024) 79
5.4.1 LIST OF MAJOR PATENTS, 2022-2023 80
TABLE 6 LIST OF MAJOR PATENTS IN CLINICAL MICROBIOLOGY MARKET, JANUARY 2022-DECEMBER 2023 80
5.5 VALUE CHAIN ANALYSIS 80
FIGURE 25 CLINICAL MICROBIOLOGY MARKET: VALUE CHAIN ANALYSIS 81
5.6 SUPPLY CHAIN ANALYSIS 82
FIGURE 26 CLINICAL MICROBIOLOGY MARKET: SUPPLY CHAIN ANALYSIS 83
5.7 TRADE ANALYSIS 83
5.7.1 TRADE ANALYSIS FOR MICROSCOPES 83
FIGURE 27 IMPORT DATA FOR MICROSCOPES, BY COUNTRY, 2019-2023 (USD THOUSAND) 83
FIGURE 28 EXPORT DATA FOR MICROSCOPES, BY COUNTRY, 2019-2023 (USD THOUSAND) 84
5.7.2 TRADE ANALYSIS FOR INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS 84
FIGURE 29 IMPORT DATA FOR INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS, BY COUNTRY, 2019-2023 (USD THOUSAND) 84
FIGURE 30 EXPORT DATA FOR INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS, BY COUNTRY, 2019-2023 (USD THOUSAND) 85
5.7.3 TRADE ANALYSIS FOR MEDICAL, SURGICAL, OR LABORATORY STERILIZERS 85
FIGURE 31 IMPORT DATA FOR MEDICAL, SURGICAL, OR LABORATORY STERILIZERS, BY COUNTRY, 2019-2023 (USD THOUSAND) 85
FIGURE 32 EXPORT DATA FOR MEDICAL, SURGICAL, OR LABORATORY STERILIZERS, BY COUNTRY, 2019-2023 (USD THOUSAND) 86
5.8 ECOSYSTEM ANALYSIS 86
FIGURE 33 CLINICAL MICROBIOLOGY MARKET: ECOSYSTEM MAP 87
5.8.1 ROLE IN ECOSYSTEM 87
TABLE 7 CLINICAL MICROBIOLOGY MARKET: ROLE IN ECOSYSTEM 87
5.9 PORTER'S FIVE FORCES ANALYSIS 88
FIGURE 34 CLINICAL MICROBIOLOGY MARKET: PORTER'S FIVE FORCES 88
5.9.1 THREAT OF NEW ENTRANTS 89
5.9.2 THREAT OF SUBSTITUTES 89
5.9.3 BARGAINING POWER OF BUYERS 89
5.9.4 BARGAINING POWER OF SUPPLIERS 89
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 89
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 90
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
FIGURE 35 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 90
TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS (%) 90
5.10.2 KEY BUYING CRITERIA 91
FIGURE 36 KEY BUYING CRITERIA FOR CLINICAL MICROBIOLOGY PRODUCTS 91
TABLE 10 KEY BUYING CRITERIA FOR CLINICAL MICROBIOLOGY PRODUCTS 91
5.11 REGULATORY LANDSCAPE 91
5.11.1 REGULATORY ANALYSIS 92
5.11.1.1 North America 92
5.11.1.1.1 US 92
5.11.1.2 Europe 92
5.11.1.3 Asia Pacific 93
5.11.1.4 Rest of the World 93
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
5.11.2.1 North America: Regulatory bodies, government agencies, and other organizations 94
5.11.2.2 Europe: Regulatory bodies, government agencies, and other organizations 94
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
5.11.2.3 Asia Pacific: Regulatory bodies, government agencies, and other organizations 95
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.11.2.4 Latin America: Regulatory bodies, government agencies, and other organizations 95
5.11.2.5 Rest of the World: Regulatory bodies, government agencies, and other organizations 96
5.12 TECHNOLOGY ANALYSIS 96
5.12.1 KEY TECHNOLOGIES 96
5.12.1.1 MALDI-TOF mass spectrometry 96
5.12.2 COMPLEMENTARY TECHNOLOGIES 96
5.12.2.1 Optical immunosensors 97
5.12.2.2 Electrochemical immunosensors 97
5.12.3 ADJACENT TECHNOLOGIES 97
5.12.3.1 Automated multiplex PCR systems 97
5.13 KEY CONFERENCES & EVENTS, 2024-2025 97
TABLE 16 CLINICAL MICROBIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2024-DECEMBER 2025 97
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 98
FIGURE 37 REVENUE SHIFT IN CLINICAL MICROBIOLOGY MARKET 99
5.15 INVESTMENT AND FUNDING SCENARIO 99
5.15.1 NUMBER OF DEALS 100
FIGURE 38 CLINICAL MICROBIOLOGY MARKET: NUMBER OF DEALS BY KEY PLAYERS, 2018-2022 100
5.15.2 VALUE OF INVESTOR DEALS 100
FIGURE 39 CLINICAL MICROBIOLOGY MARKET: VALUE OF INVESTOR DEALS, 2018-2022 (USD MILLION) 100
5.16 UNMET NEEDS 101
6 CLINICAL MICROBIOLOGY MARKET, BY APPLICATION 102
6.1 INTRODUCTION 103
TABLE 17 CLINICAL MICROBIOLOGY MARKET, BY APPLICATION, 2022-2029 (USD MILLION) 103
6.2 PHARMACEUTICAL APPLICATIONS 103
6.2.1 PRESENCE OF WELL-ESTABLISHED PLAYERS AND INCREASED DRUG DEVELOPMENT PIPELINE TO AID MARKET GROWTH 103
TABLE 18 CLINICAL MICROBIOLOGY MARKET FOR PHARMACEUTICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 104
6.3 CLINICAL APPLICATIONS 104
6.3.1 RISING PREVALENCE OF INFECTIOUS DISEASES AND INCREASING FOCUS ON EARLY DIAGNOSIS TO DRIVE MARKET 104
TABLE 19 CLINICAL MICROBIOLOGY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 105
6.4 FOOD TESTING APPLICATIONS 106
6.4.1 HIGH DEMAND FOR PACKAGED FOOD AND EXPANSION OF DAIRY INDUSTRY TO SUPPORT MARKET GROWTH 106
TABLE 20 CLINICAL MICROBIOLOGY MARKET FOR FOOD TESTING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 107
6.5 ENERGY APPLICATIONS 107
6.5.1 INCREASING FOCUS ON ENERGY-EFFICIENT BIOFUEL DEVELOPMENT TO BOOST MARKET GROWTH 107
TABLE 21 CLINICAL MICROBIOLOGY MARKET FOR ENERGY APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 108
6.6 CHEMICAL & MATERIAL MANUFACTURING APPLICATIONS 108
6.6.1 INCREASED USE OF MICROBE-DERIVED DYES TO FUEL MARKET GROWTH 108
TABLE 22 CLINICAL MICROBIOLOGY MARKET FOR CHEMICAL & MATERIAL MANUFACTURING APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 109
6.7 ENVIRONMENTAL APPLICATIONS 109
6.7.1 RISING PREVALENCE OF AIR- AND WATER-BORNE DISEASES TO PROPEL MARKET GROWTH 109
TABLE 23 CLINICAL MICROBIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2022-2029 (USD MILLION) 110
7 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA 111
7.1 INTRODUCTION 112
TABLE 24 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2022-2029 (USD MILLION) 112
7.2 RESPIRATORY DISEASES 112
7.2.1 INCREASING CLINICAL RESEARCH ACTIVITIES FOR ADVANCED DRUG DEVELOPMENT TO DRIVE MARKET 112
TABLE 25 CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2022-2029 (USD MILLION) 114
7.3 BLOODSTREAM INFECTIONS 114
7.3.1 GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO PROPEL MARKET GROWTH 114
TABLE 26 CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY REGION, 2022-2029 (USD MILLION) 115
7.4 GASTROINTESTINAL DISEASES 115
7.4.1 HIGH RISK OF FOOD- AND WATER-BORNE INFECTIONS TO AID MARKET GROWTH 115
TABLE 27 CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2022-2029 (USD MILLION) 116
7.5 SEXUALLY TRANSMITTED DISEASES 116
7.5.1 INCREASING EMPHASIS ON EARLY AND EFFECTIVE DISEASE DIAGNOSIS TO BOOST MARKET GROWTH 116
TABLE 28 CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2022-2029 (USD MILLION) 117
7.6 URINARY TRACT INFECTIONS 117
7.6.1 RISING NUMBER OF CLINICAL TRIALS FOR DEVELOPMENT OF NEW ANTIBIOTICS TO SUPPORT MARKET GROWTH 117
TABLE 29 CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2022-2029 (USD MILLION) 118
7.7 PERIODONTAL DISEASES 119
7.7.1 INCREASING R&D INITIATIVES TO STUDY MICROBE-INDUCED DISEASES TO FUEL MARKET GROWTH 119
TABLE 30 CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY REGION, 2022-2029 (USD MILLION) 119
7.8 OTHER DISEASES 120
TABLE 31 CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2022-2029 (USD MILLION) 120
8 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT 121
8.1 INTRODUCTION 122
TABLE 32 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 122
8.2 INSTRUMENTS 122
TABLE 33 CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 123
TABLE 34 CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY DISEASE AREA, 2022-2029 (USD MILLION) 123
TABLE 35 CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY END USER, 2022-2029 (USD MILLION) 124
TABLE 36 CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION) 124
8.2.1 LABORATORY INSTRUMENTS 124
TABLE 37 LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 125
TABLE 38 LABORATORY INSTRUMENTS MARKET, BY DISEASE AREA, 2022-2029 (USD MILLION) 126
TABLE 39 LABORATORY INSTRUMENTS MARKET, BY END USER, 2022-2029 (USD MILLION) 126
TABLE 40 LABORATORY INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 127
8.2.1.1 Incubators 127
8.2.1.1.1 Rising demand for cell culture applications to drive segment 127
TABLE 41 INCUBATORS MARKET, BY REGION, 2022-2029 (USD MILLION) 127
8.2.1.2 Gram stainers 128
8.2.1.2.1 Faster and more accurate screening of bacterial pathogens to propel segment growth 128
TABLE 42 GRAM STAINERS MARKET, BY REGION, 2022-2029 (USD MILLION) 128
8.2.1.3 Bacterial colony counters 128
8.2.1.3.1 Increased focus on accurate bacterial quantification to fuel segment growth 128
TABLE 43 BACTERIAL COLONY COUNTERS MARKET, BY REGION, 2022-2029 (USD MILLION) 129
8.2.1.4 Autoclave sterilizers 129
8.2.1.4.1 Growing need for infection control in healthcare facilities to support market growth 129
TABLE 44 AUTOCLAVE STERILIZERS MARKET, BY REGION, 2022-2029 (USD MILLION) 129
8.2.1.5 Microbial air samplers 130
8.2.1.5.1 Need for enhanced air quality monitoring in cleanrooms to accelerate segment growth 130
TABLE 45 MICROBIAL AIR SAMPLERS MARKET, BY REGION, 2022-2029 (USD MILLION) 130
8.2.1.6 Anaerobic culture systems 130
8.2.1.6.1 Increased research on anaerobic microorganisms to boost segment growth 130
TABLE 46 ANAEROBIC CULTURE SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION) 131
8.2.1.7 Petri dish fillers 131
8.2.1.7.1 Need for minimal bench space and effective control with graphical user interfaces to aid segment growth 131
TABLE 47 PETRI DISH FILLERS MARKET, BY REGION, 2022-2029 (USD MILLION) 131
8.2.1.8 Blood culture systems 132
8.2.1.8.1 Technological advancements in diagnostic testing to drive segment 132
TABLE 48 BLOOD CULTURE SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION) 132
8.2.1.9 Microbial culture systems 132
8.2.1.9.1 Increase in biopharmaceutical research to augment segment growth 132
TABLE 49 MICROBIAL CULTURE SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION) 133
8.2.1.10 Other laboratory instruments 133
TABLE 50 OTHER LABORATORY INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 133
8.2.2 MICROBIOLOGY ANALYZERS 134
TABLE 51 LIST OF COMMERCIALLY AVAILABLE MICROBIOLOGY ANALYZERS, 2023-2024 134
TABLE 52 MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 134
TABLE 53 MICROBIOLOGY ANALYZERS MARKET, BY DISEASE AREA, 2022-2029 (USD MILLION) 135
TABLE 54 MICROBIOLOGY ANALYZERS MARKET, BY END USER, 2022-2029 (USD MILLION) 135
TABLE 55 MICROBIOLOGY ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION) 136
8.2.2.1 Molecular diagnostic instruments 136
8.2.2.1.1 Advancements in multiplexing techniques and high adoption of genomics-based analysis to aid market growth 136
TABLE 56 MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 137
8.2.2.2 Microscopes 137
8.2.2.2.1 Rising demand for high-resolution imaging to propel market growth 137
TABLE 57 MICROSCOPES MARKET, BY REGION, 2022-2029 (USD MILLION) 138
8.2.2.3 Mass spectrometers 138
8.2.2.3.1 Increased applications in proteomics and metabolomics to boost market growth 138
TABLE 58 MASS SPECTROMETERS MARKET, BY REGION, 2022-2029 (USD MILLION) 138
8.3 REAGENTS 139
TABLE 59 CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 139
TABLE 60 CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY DISEASE AREA, 2022-2029 (USD MILLION) 140
TABLE 61 CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY END USER, 2022-2029 (USD MILLION) 140
TABLE 62 CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY REGION, 2022-2029 (USD MILLION) 141
8.3.1 PATHOGEN-SPECIFIC KITS 141
8.3.1.1 Growing private-public initiatives for research to support market growth 141
TABLE 63 PATHOGEN-SPECIFIC KITS MARKET, BY DISEASE AREA, 2022-2029 (USD MILLION) 142
TABLE 64 PATHOGEN-SPECIFIC KITS MARKET, BY END USER, 2022-2029 (USD MILLION) 142
TABLE 65 PATHOGEN-SPECIFIC KITS MARKET, BY REGION, 2022-2029 (USD MILLION) 143
8.3.2 GENERAL REAGENTS 143
8.3.2.1 Rising demand for diagnostic tests for pathogen detection to propel segment growth 143
TABLE 66 GENERAL REAGENTS MARKET, BY DISEASE AREA, 2022-2029 (USD MILLION) 144
TABLE 67 GENERAL REAGENTS MARKET, BY END USER, 2022-2029 (USD MILLION) 144
TABLE 68 GENERAL REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION) 145
8.4 MEDIA & SERA 145
8.4.1 RISING DEMAND FOR STANDARDIZED CULTURE MEDIA FOR MICROBIOLOGICAL TESTING TO DRIVE MARKET 145
TABLE 69 CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY DISEASE AREA, 2022-2029 (USD MILLION) 146
TABLE 70 CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY END USER, 2022-2029 (USD MILLION) 146
TABLE 71 CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY REGION, 2022-2029 (USD MILLION) 147
9 CLINICAL MICROBIOLOGY MARKET, BY END USER 148
9.1 INTRODUCTION 149
TABLE 72 NUMBER OF CLINICAL LABORATORIES, BY TIER, 2023 149
TABLE 73 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2022-2029 (USD MILLION) 149
9.2 HOSPITALS & DIAGNOSTIC CENTERS 150
9.2.1 GROWING INCIDENCE OF TARGET DISEASES TO DRIVE MARKET 150
TABLE 74 CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022-2029 (USD MILLION) 150
9.3 CONTRACT TESTING LABORATORIES 151
9.3.1 CONTINUOUS OUTSOURCING OF DRUG TESTING PROCEDURES TO LABORATORY SERVICE PROVIDERS TO AID MARKET GROWTH 151
TABLE 75 CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY REGION, 2022-2029 (USD MILLION) 151
9.4 ACADEMIC & RESEARCH INSTITUTES 152
9.4.1 INCREASED USE OF ADVANCED MOLECULAR DIAGNOSTIC PRODUCTS FOR DISEASE DIAGNOSIS TO AUGMENT MARKET GROWTH 152
TABLE 76 CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION) 152
10 CLINICAL MICROBIOLOGY MARKET, BY REGION 153
10.1 INTRODUCTION 154
TABLE 77 SALES VOLUME IN US, UK, AND CHINA, BY PRODUCT TYPE (2023) 154
TABLE 78 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2022-2029 (USD MILLION) 154
10.2 NORTH AMERICA 155
FIGURE 40 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 156
TABLE 79 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 157
TABLE 80 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 157
TABLE 81 NORTH AMERICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 158
TABLE 82 NORTH AMERICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 158
TABLE 83 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 159
TABLE 84 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2022-2029 (USD MILLION) 159
TABLE 85 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2022-2029(USD MILLION) 160
TABLE 86 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 160
10.2.1 NORTH AMERICA: RECESSION IMPACT 160
10.2.2 US 161
10.2.2.1 US to dominate clinical microbiology market during study period 161
TABLE 87 US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 161
TABLE 88 US: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 162
TABLE 89 US: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 162
TABLE 90 US: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 163
TABLE 91 US: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 163
10.2.3 CANADA 163
10.2.3.1 Supportive government initiatives and increased research funding to boost market growth 163
TABLE 92 CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 164
TABLE 93 CANADA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 164
TABLE 94 CANADA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 165
TABLE 95 CANADA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 165
TABLE 96 CANADA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 166
10.3 EUROPE 166
TABLE 97 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 167
TABLE 98 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 167
TABLE 99 EUROPE: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 168
TABLE 100 EUROPE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 168
TABLE 101 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 169
TABLE 102 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2022-2029 (USD MILLION) 169
TABLE 103 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2022-2029 (USD MILLION) 170
TABLE 104 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 170
10.3.1 EUROPE: RECESSION IMPACT 171
10.3.2 GERMANY 171
10.3.2.1 Growing outsourcing of diagnostic testing by hospitals to fuel market growth 171
TABLE 105 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 172
TABLE 106 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 107 GERMANY: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 173
TABLE 108 GERMANY: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 173
TABLE 109 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 174
10.3.3 UK 174
10.3.3.1 Rising acceptance of genome-based diagnostic techniques to fuel market growth 174
TABLE 110 UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 175
TABLE 111 UK: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 175
TABLE 112 UK: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 176
TABLE 113 UK: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 176
TABLE 114 UK: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 177
10.3.4 FRANCE 177
10.3.4.1 Favorable healthcare reforms and investments in diagnostic infrastructure to propel market growth 177
TABLE 115 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 178
TABLE 116 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 178
TABLE 117 FRANCE: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 179
TABLE 118 FRANCE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 179
TABLE 119 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 180
10.3.5 ITALY 180
10.3.5.1 Improved healthcare services and better disease surveillance to fuel market growth 180
TABLE 120 ITALY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 181
TABLE 121 ITALY: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 181
TABLE 122 ITALY: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 123 ITALY: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 124 ITALY: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 183
10.3.6 SPAIN 183
10.3.6.1 Well-established research centers and stringent food regulations to augment market growth 183
TABLE 125 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 184
TABLE 126 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 184
TABLE 127 SPAIN: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 128 SPAIN: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 129 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 186
10.3.7 REST OF EUROPE 186
TABLE 130 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029(USD MILLION) 186
TABLE 131 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 187
TABLE 132 REST OF EUROPE: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 187
TABLE 133 REST OF EUROPE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 188
TABLE 134 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 188
10.4 ASIA PACIFIC 188
FIGURE 41 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 189
TABLE 135 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029(USD MILLION) 190
TABLE 136 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 190
TABLE 137 ASIA PACIFIC: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 191
TABLE 138 ASIA PACIFIC: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 191
TABLE 139 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 192
TABLE 140 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2022-2029 (USD MILLION) 192
TABLE 141 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2022-2029 (USD MILLION) 193
TABLE 142 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 193
10.4.1 ASIA PACIFIC: RECESSION IMPACT 194
10.4.2 JAPAN 194
10.4.2.1 Technological advancements in healthcare and high geriatric population to aid market growth 194
TABLE 143 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 194
TABLE 144 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 145 JAPAN: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 146 JAPAN: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 196
TABLE 147 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 196
10.4.3 CHINA 196
10.4.3.1 Increasing government focus on disease prevention to drive market 196
TABLE 148 CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 197
TABLE 149 CHINA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 150 CHINA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 151 CHINA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 199
TABLE 152 CHINA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 199
10.4.4 INDIA 199
10.4.4.1 Rapidly increasing population and high incidence of infectious diseases to propel market growth 199
TABLE 153 INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 200
TABLE 154 INDIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 155 INDIA LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 156 INDIA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 157 INDIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 202
10.4.5 AUSTRALIA 202
10.4.5.1 Rising public-private investments and growing research on diagnostic applications to drive market 202
TABLE 158 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 203
TABLE 159 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 203
TABLE 160 AUSTRALIA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 161 AUSTRALIA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 162 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 205
10.4.6 SOUTH KOREA 205
10.4.6.1 Strong government support and increased adoption of advanced diagnostic technologies to aid market growth 205
TABLE 163 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 205
TABLE 164 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 165 SOUTH KOREA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 166 SOUTH KOREA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 207
TABLE 167 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 207
10.4.7 REST OF ASIA PACIFIC 207
TABLE 168 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 208
TABLE 169 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 208
TABLE 170 REST OF ASIA PACIFIC: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 171 REST OF ASIA PACIFIC: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 172 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 210
10.5 LATIN AMERICA 210
TABLE 173 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 211
TABLE 174 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 211
TABLE 175 LATIN AMERICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 176 LATIN AMERICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 177 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 178 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2022-2029 (USD MILLION) 213
TABLE 179 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2022-2029 (USD MILLION) 214
TABLE 180 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2022-2029 (USD MILLION) 214
10.5.1 LATIN AMERICA: RECESSION IMPACT 214
10.5.2 BRAZIL 215
10.5.2.1 High healthcare expenditure and presence of key manufacturers to support market growth 215
TABLE 181 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 215
TABLE 182 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 183 BRAZIL: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 184 BRAZIL: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 185 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 217
10.5.3 MEXICO 217
10.5.3.1 Supportive government initiatives and increased healthcare investments to augment market growth 217
TABLE 186 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 218
TABLE 187 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 218
TABLE 188 MEXICO: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 219
TABLE 189 MEXICO: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 219
TABLE 190 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 220
10.5.4 REST OF LATIN AMERICA 220
TABLE 191 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 221
TABLE 192 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 221
TABLE 193 REST OF LATIN AMERICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 194 REST OF LATIN AMERICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 222
TABLE 195 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 223

10.6 MIDDLE EAST & AFRICA 223
TABLE 196 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 224
TABLE 197 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 224
TABLE 198 MIDDLE EAST & AFRICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 225
TABLE 199 MIDDLE EAST & AFRICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 225
TABLE 200 MIDDLE EAST AND AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 226
TABLE 201 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2022-2029 (USD MILLION) 226
TABLE 202 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2022-2029 (USD MILLION) 227
TABLE 203 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2022-2029(USD MILLION) 227
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 227
10.6.2 GCC COUNTRIES 228
10.6.2.1 High incidence of infectious diseases and technological advancements to fuel market growth 228
TABLE 204 GCC COUNTRIES: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 228
TABLE 205 GCC COUNTRIES: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 206 GCC COUNTRIES: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 229
TABLE 207 GCC COUNTRIES: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 229
TABLE 208 GCC COUNTRIES: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 230
10.6.3 REST OF MIDDLE EAST & AFRICA 230
TABLE 209 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2022-2029(USD MILLION) 231
TABLE 210 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION) 231
TABLE 211 REST OF MIDDLE EAST & AFRICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION) 232
TABLE 212 REST OF MIDDLE EAST & AFRICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2022-2029 (USD MILLION) 232
TABLE 213 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2022-2029 (USD MILLION) 233
11 COMPETITIVE LANDSCAPE 234
11.1 INTRODUCTION 234
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 234
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET 235
FIGURE 42 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 235
11.3 REVENUE ANALYSIS 236
FIGURE 43 REVENUE ANALYSIS FOR KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET (2021-2023) 237
11.4 MARKET SHARE ANALYSIS 238
FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET (2023) 238
TABLE 214 CLINICAL MICROBIOLOGY MARKET: DEGREE OF COMPETITION 238
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 239
11.5.1 STARS 239
11.5.2 PERVASIVE PLAYERS 239
11.5.3 EMERGING LEADERS 240
11.5.4 PARTICIPANTS 240
FIGURE 45 CLINICAL MICROBIOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 240
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 241
11.5.5.1 Company footprint 241
FIGURE 46 CLINICAL MICROBIOLOGY MARKET: COMPANY FOOTPRINT 241
11.5.5.2 Product footprint 242
TABLE 215 CLINICAL MICROBIOLOGY MARKET: PRODUCT FOOTPRINT 242
11.5.5.3 Application footprint 243
TABLE 216 CLINICAL MICROBIOLOGY MARKET: APPLICATION FOOTPRINT 243
11.5.5.4 End user footprint 244
TABLE 217 CLINICAL MICROBIOLOGY MARKET: END USER FOOTPRINT 244
11.5.5.5 Region footprint 245
TABLE 218 CLINICAL MICROBIOLOGY MARKET: REGION FOOTPRINT 245
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 245
11.6.1 PROGRESSIVE COMPANIES 245
11.6.2 DYNAMIC COMPANIES 245
11.6.3 RESPONSIVE COMPANIES 246
11.6.4 STARTING BLOCKS 246
FIGURE 47 CLINICAL MICROBIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 246
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 247
TABLE 219 CLINICAL MICROBIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 247
TABLE 220 CLINICAL MICROBIOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 248
11.7 VALUATION & FINANCIAL METRICS 249
FIGURE 48 EV/EBITDA OF KEY VENDORS 249
FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS 249
11.8 BRAND/PRODUCT COMPARISON 250
FIGURE 50 CLINICAL MICROBIOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 250
11.9 COMPETITIVE SCENARIO 251
11.9.1 PRODUCT LAUNCHES 251
TABLE 221 CLINICAL MICROBIOLOGY MARKET: PRODUCTS LAUNCHES,
JANUARY 2021-MAY 2024 251
11.9.2 DEALS 252
TABLE 222 CLINICAL MICROBIOLOGY MARKET: DEALS, JANUARY 2021-MAY 2024 252
11.9.3 OTHER DEVELOPMENTS 253
TABLE 223 CLINICAL MICROBIOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024 253
12 COMPANY PROFILES 254
12.1 KEY PLAYERS 254
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 BIOMERIEUX 254
TABLE 224 BIOMERIEUX: COMPANY OVERVIEW 254
FIGURE 51 BIOMERIEUX: COMPANY SNAPSHOT (2023) 255
TABLE 225 BIOMERIEUX: PRODUCTS/SERVICES/SOLUTIONS OFFERED 255
TABLE 226 BIOMERIEUX: DEALS, JANUARY 2021-MAY 2024 259
12.1.2 DANAHER CORPORATION 261
TABLE 227 DANAHER CORPORATION: COMPANY OVERVIEW 261
FIGURE 52 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 262
TABLE 228 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 263
TABLE 229 DANAHER CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024 265
12.1.3 BECTON, DICKINSON AND COMPANY 267
FIGURE 53 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023) 268
TABLE 231 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 268
TABLE 232 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 271
TABLE 233 BECKTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021-MAY 2024 272
TABLE 234 BECKTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024 273
12.1.4 ABBOTT 275
FIGURE 54 ABBOTT: COMPANY SNAPSHOT (2023) 276
TABLE 236 ABBOTT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 276
TABLE 237 ABBOTT: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024 283
12.1.5 F. HOFFMANN-LA ROCHE LTD. 285
FIGURE 55 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023) 286
TABLE 239 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 286
TABLE 240 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES,
JANUARY 2021-MAY 2024 287
TABLE 241 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021-MAY 2024 287
TABLE 242 F. HOFFMAN-LA ROCHE LTD.: OTHER DEVELOPMENTS,
JANUARY 2021-MAY 2024 288
12.1.6 THERMO FISHER SCIENTIFIC INC. 290
TABLE 243 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 290
FIGURE 56 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 291
TABLE 244 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 292
TABLE 245 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 295
TABLE 246 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-MAY 2024 296
12.1.7 AGILENT TECHNOLOGIES, INC. 297
FIGURE 57 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023) 298
TABLE 248 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 298
TABLE 249 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021-MAY 2024 299
12.1.8 BRUKER 300
TABLE 250 BRUKER: COMPANY OVERVIEW 300
FIGURE 58 BRUKER: COMPANY SNAPSHOT (2022) 301
TABLE 251 BRUKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED 301
TABLE 252 BRUKER: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 302
TABLE 253 BRUKER: DEALS, JANUARY 2021-MAY 2024 302
12.1.9 HOLOGIC, INC. 303
TABLE 254 HOLOGIC, INC.: COMPANY OVERVIEW 303
FIGURE 59 HOLOGIC, INC.: COMPANY SNAPSHOT (2023) 304
TABLE 255 HOLOGIC, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 304
TABLE 256 HOLOGIC, INC.: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 306
TABLE 257 HOLOGIC, INC.: DEALS, JANUARY 2021-MAY 2024 306
12.1.10 MERCK KGAA 307
TABLE 258 MERCK KGAA: COMPANY OVERVIEW 307
FIGURE 60 MERCK KGAA: COMPANY SNAPSHOT (2022) 308
TABLE 259 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 308
TABLE 260 MERCK KGAA: DEALS, JANUARY 2021-MAY 2024 309
TABLE 261 MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024 310
12.1.11 BIO-RAD LABORATORIES, INC. 311
TABLE 262 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 311
FIGURE 61 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023) 312
TABLE 263 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 312
TABLE 264 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021-MAY 2024 314
TABLE 265 BIO-RAD LABORATORIES, INC.: OTHER DEVELOPMENTS, JANUARY 2021-MAY 2024 314
12.1.12 QIAGEN 315
TABLE 266 QIAGEN: COMPANY OVERVIEW 315
FIGURE 62 QIAGEN: COMPANY SNAPSHOT (2023) 316
TABLE 267 QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED 316
TABLE 268 QIAGEN: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024 317
TABLE 269 QIAGEN: DEALS, JANUARY 2021-MAY 2024 317
12.1.13 SHIMADZU CORPORATION 318
TABLE 270 SHIMADZU CORPORATION: COMPANY OVERVIEW 318
FIGURE 63 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2022) 319
TABLE 271 SHIMADZU CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 319
12.1.14 NEOGEN CORPORATION 320
TABLE 272 NEOGEN CORPORATION: COMPANY OVERVIEW 320
FIGURE 64 NEOGEN CORPORATION: COMPANY SNAPSHOT (2023) 321
TABLE 273 NEOGEN CORPORATION: PRODUCTS/ SERVICES/SOLUTIONS OFFERED 322
TABLE 274 NEOGEN CORPORATION: DEALS, JANUARY 2021-MAY 2024 323
12.1.15 SIEMENS HEALTHINEERS AG 324
TABLE 275 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 324
FIGURE 65 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 325
TABLE 276 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 326
12.1.16 HARDY DIAGNOSTICS 327
TABLE 277 HARDY DIAGNOSTICS: COMPANY OVERVIEW 327
TABLE 278 HARDY DIAGNOSTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 328
12.1.17 EMSL ANALYTICAL, INC. 332
TABLE 279 EMSL ANALYTICAL, INC.: COMPANY OVERVIEW 332
TABLE 280 EMSL ANALYTICAL, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 332
12.1.18 LIOFILCHEM SRL 333
TABLE 281 LIOFILCHEM SRL: COMPANY OVERVIEW 333
TABLE 282 LIOFILCHEM SRL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 334
12.1.19 TCS BIOSCIENCES 335
TABLE 283 TCS BIOSCIENCES: COMPANY OVERVIEW 335
TABLE 284 TCS BIOSCIENCES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 335
12.1.20 COLE-PARMER INSTRUMENT COMPANY, LLC 336
TABLE 285 COLE-PARMER INSTRUMENT COMPANY, LLC: COMPANY OVERVIEW 336
TABLE 286 COLE-PARMER INSTRUMENT COMPANY, LLC: PRODUCTS/SERVICES/ SOLUTIONS OFFERED 336
12.2 OTHER PLAYERS 337
12.2.1 MEMMERT GMBH + CO.KG 337
TABLE 287 MEMMERT GMBH + CO.KG COMPANY OVERVIEW 337
12.2.2 VACUTEST KIMA S.R.L 338
TABLE 288 VACUTEST KIMA S.R.L.: COMPANY OVERVIEW 338
12.2.3 RAPID MICRO BIOSYSTEMS, INC. 339
TABLE 289 RAPID MICRO BIOSYSTEMS, INC..: COMPANY OVERVIEW 339
12.2.4 BIOTECHNOLOGY SOLUTIONS TX, LLC 340
TABLE 290 RAPID MICRO BIOSYSTEMS, INC.: COMPANY OVERVIEW 340
12.2.5 ARROW DIAGNOSTICS 341
TABLE 291 ARROW DIAGNOSTICS: COMPANY OVERVIEW 341
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 342
13.1 DISCUSSION GUIDE 342
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 347
13.3 CUSTOMIZATION OPTIONS 349
13.4 RELATED REPORTS 349
13.5 AUTHOR DETAILS 350

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $4950.00
  • $6650.00
  • $8150.00
  • $10000.00
  • ADD TO BASKET
  • BUY NOW

Related Reports

Titanium Market by Product Type (Titanium Dioxide, Titanium Metal), Titanium Dioxide End-use Industry (Paints & Coatings, Plastics & Rubber, Paper), Titanium Metal End-use Industry (Aerospace & Defense, Chemical & Process Industry, Energy & Power, Desalination), and Region - Global Forecast to 2030
 Market Report I 2025-05-13 I 314 Pages
Orthodontic Supplies Market by Product (Removable, Fixed (Bracket (Type, Material), Archwires, Anchorage, Ligature), Adhesive, Accessories), Patient, Distribution Channel (ePlatforms), End User (Dental Hospitals, DSOs) - Global forecast to 2030
 Market Report I 2025-05-12 I 327 Pages
ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030
 Market Report I 2025-05-12 I 334 Pages

Don't forget we can help save time with your search, contact us and we'll prepare and send options

Syntactic Foam Market by Product Type (Macro-sphere, Micro-sphere), Matrix Type (Metal, Polymer, Ceramic), Filler Type (Glass and Ceramic Micro-spheres), Foam (Block, Sheet & Rod), Chemistry (Epoxy, Polypropylene), End-use Industry & Region - Global Forecast to 2030
 Market Report I 2025-05-09 I 260 Pages
In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030
 Market Report I 2025-05-09 I 740 Pages